Yifan Pharmaceutical Co., Ltd.
SZSE:002019.SZ
12.27 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||||||
| Net Income
| -551.073 | 127.154 | 242.214 | 931.394 | 873.116 | 693.675 | 1,265.658 | 683.396 | 361.962 | 237.938 | 25.609 | 11.319 | -236.834 | -201.509 | 30.37 | 41.237 | 240.189 | 1.945 | 20.511 | 32.516 | 25.878 |
| Depreciation & Amortization
| 279.816 | 228.43 | 207.176 | 177.011 | 153.689 | 121.51 | 106.485 | 87.33 | 71.122 | 21.741 | 52.825 | 51.334 | 43.196 | 40.565 | 36.085 | 32.795 | 25.251 | 32.055 | 32.588 | 23.518 | 14.616 |
| Deferred Income Tax
| -52.719 | -53.937 | -87.024 | -33.439 | -44.489 | -4.602 | -36.919 | -19.508 | 5.95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | -6.977 | 82.834 | 47.771 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -34.963 | -168.181 | -285.426 | -178.504 | -275.13 | 226.225 | -407.94 | 18.635 | -79.824 | -131.519 | -14.377 | -45.853 | -61.184 | -41.622 | -17.752 | -16.273 | -32.027 | -19.46 | -39.256 | -23.856 | -30.733 |
| Accounts Receivables
| -10.248 | -103.773 | -18.586 | -117.709 | -58.047 | 185.23 | -191.062 | -444.144 | -133.309 | -221.879 | 28.918 | -64.186 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -109.389 | -167.101 | -80.481 | 21.86 | -113.484 | -6.953 | -17.273 | -8.008 | -56.094 | -26.467 | 0.46 | 11.513 | -58.091 | -36.958 | 26.487 | -37.618 | -38.43 | 10.676 | -23.84 | -25 | -12.425 |
| Accounts Payables
| 62.881 | 156.63 | -99.335 | -49.216 | -59.11 | 52.55 | -162.686 | 490.296 | 103.629 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 21.793 | -53.937 | -87.024 | -33.439 | -44.489 | 233.178 | -390.668 | 26.644 | -23.73 | -105.051 | -14.838 | -57.367 | -3.092 | -4.664 | -44.239 | 21.345 | 6.402 | -30.136 | -15.416 | 1.144 | -18.308 |
| Other Non Cash Items
| 1,328.213 | 284.662 | 231.268 | 129.211 | 182.284 | 129.49 | 168.526 | 66.485 | 48.701 | 11.575 | 37.992 | 13.083 | 201.999 | 168.742 | 9.91 | 25.548 | 15.292 | 18.077 | 10.281 | 1.409 | 2.894 |
| Operating Cash Flow
| 352.885 | 472.065 | 301.231 | 1,108.506 | 937.24 | 1,170.901 | 1,132.729 | 855.846 | 401.96 | 139.735 | 102.048 | 29.882 | -52.823 | -33.825 | 58.612 | 83.307 | 248.705 | 32.616 | 24.124 | 33.587 | 12.655 |
| Investing Activities: | |||||||||||||||||||||
| Investments In Property Plant And Equipment
| -504.086 | -542.274 | -571.74 | -715.707 | -866.073 | -729.212 | -485.859 | -287.505 | -217.153 | -89.509 | -73.947 | -67.639 | -99.742 | -199.322 | -151.269 | -122.457 | -172.065 | -57.622 | -58.634 | -70.14 | -52.435 |
| Acquisitions Net
| 6.427 | 1.2 | -26.096 | -36.815 | -818.808 | -449.083 | -506.719 | -599.14 | -563.045 | -52.543 | 154.904 | 31.2 | 0 | 1.454 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -1,487.405 | -1,253.58 | -1,265 | -1,141 | -922.93 | -825.5 | -2,151.222 | -687.8 | -445 | -217.5 | -153 | 42.016 | 0 | -80 | 0 | 0 | -12 | -10.22 | -92.591 | 0 | 0 |
| Sales Maturities Of Investments
| 1,448.279 | 1,118.031 | 1,337.242 | 1,122.009 | 1,020.535 | 1,386.579 | 1,586.35 | 539.655 | 395.871 | 258.836 | 10 | 56.64 | 41.313 | 8.956 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -28.749 | 6.459 | 17.702 | 0.96 | 0.816 | 0.689 | 2.041 | 3.259 | 1.416 | 65.544 | 12.2 | 3.979 | 4.965 | 2.534 | 4.273 | 8.754 | 1.433 | 0.606 | 18.471 | -14.892 | 3.156 |
| Investing Cash Flow
| -536.786 | -670.165 | -507.891 | -770.554 | -1,586.459 | -616.527 | -1,555.408 | -1,031.53 | -827.911 | -35.172 | -49.843 | 66.195 | -53.465 | -266.378 | -140.996 | -113.703 | -182.632 | -67.236 | -132.755 | -85.032 | -49.28 |
| Financing Activities: | |||||||||||||||||||||
| Debt Repayment
| -168.097 | -1,880.31 | -2,432.655 | -2,210.003 | -2,068.975 | -1,820.251 | -507.006 | -1,116.903 | -818.826 | -126.778 | -545.658 | -586 | -434.129 | -230 | -290 | -219 | -235 | -143 | -98 | -102.586 | -46.164 |
| Common Stock Issued
| 0 | 0.846 | 1.002 | 1.615 | 0 | 0 | -8.909 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -37.999 | -53.56 | -121.471 | -1.615 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -72.466 | -1.205 | -61.671 | -123.427 | -120.697 | -543.45 | -176.373 | -96.71 | -65.392 | -6.231 | -28.028 | -32.215 | -27.965 | -38.728 | -29.077 | -32.384 | -30.359 | -20.303 | -16.652 | -3.499 | -15.58 |
| Other Financing Activities
| 257.802 | 2,006.744 | 2,913.671 | 1,844.035 | 2,412.401 | 2,116.98 | 1,767.736 | 1,877.885 | 1,298.148 | 140 | 528.271 | 462.658 | 550.129 | 496.5 | 566.015 | 235 | 226 | 221.048 | 185.67 | 233.001 | 85.586 |
| Financing Cash Flow
| 30.427 | -12.665 | 222.158 | -567.946 | 151.09 | -246.721 | 1,084.358 | 664.272 | 413.93 | 6.99 | -45.414 | -155.558 | 88.035 | 227.772 | 246.938 | -16.384 | -39.359 | 57.744 | 71.018 | 126.915 | 23.842 |
| Other Information: | |||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 14.593 | 59.563 | -20.854 | 1.332 | 9.58 | -2.956 | -23.067 | -12.609 | -5.228 | -2.589 | 0 | 0 | 0 | 0 | -0.027 | -0 | -0 | 0 | -0 | 0 | 0 |
| Net Change In Cash
| -445.415 | -151.202 | -5.357 | -228.662 | -488.549 | 304.697 | 638.611 | 475.978 | -17.248 | 108.965 | 6.791 | -59.48 | -18.252 | -72.431 | 164.527 | -46.78 | 26.714 | 23.125 | -37.613 | 75.471 | -12.783 |
| Cash At End Of Period
| 698.368 | 711.626 | 862.827 | 868.184 | 1,096.846 | 1,585.395 | 1,280.698 | 642.087 | 166.109 | 183.358 | 70.709 | 63.918 | 123.399 | 141.651 | 214.082 | 49.554 | 96.334 | 69.62 | 46.495 | 84.108 | 8.637 |